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Objective: To examine whether established diabetes risk factors and diabetes risk algorithms are asso-
ciated with future frailty.
Design: Prospective cohort study. Risk algorithms at baseline (1997e1999) were the Framingham
Offspring, Cambridge, and Finnish diabetes risk scores.
Setting: Civil service departments in London, United Kingdom.
Participants: There were 2707 participants (72% men) aged 45 to 69 years at baseline assessment and free
of diabetes.
Measurements: Risk factors (age, sex, family history of diabetes, body mass index, waist circumference,
systolic and diastolic blood pressure, antihypertensive and corticosteroid treatments, history of high
blood glucose, smoking status, physical activity, consumption of fruits and vegetables, fasting glucose,
HDL-cholesterol, and triglycerides) were used to construct the risk algorithms. Frailty, assessed during
a resurvey in 2007e2009, was denoted by the presence of 3 or more of the following indicators: self-
reported exhaustion, low physical activity, slow walking speed, low grip strength, and weight loss;
“prefrailty” was deﬁned as having 2 or fewer of these indicators.
Results: After a mean follow-up of 10.5 years, 2.8% of the sample was classiﬁed as frail and 37.5% as
prefrail. Increased age, being female, stopping smoking, low physical activity, and not having a daily
consumption of fruits and vegetables were each associated with frailty or prefrailty. The Cambridge and
Finnish diabetes risk scores were associated with frailty/prefrailty with odds ratios per 1 SD increase
(disadvantage) in score of 1.18 (95% conﬁdence interval: 1.09e1.27) and 1.27 (1.17e1.37), respectively.
Conclusion: Selected diabetes risk factors and risk scores are associated with subsequent frailty. Risk
scores may have utility for frailty prediction in clinical practice.
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K. Bouillon et al. / JAMDA 14 (2013) 851.e1e851.e6851.e2Aging is associated with multisystem decline, which can lead
to frailty, a clinically recognized geriatric syndrome characterized by
declines in functioning across an array of physiologic systems.1 Frailty
itself has a series of negative consequences, including a future risk
of disability,2 institutionalization,3 fracture,4 hospitalization,5 and
mortality.4,6 Identiﬁcation of modiﬁable risk factors for frailty7 is
clearly important in the prevention of the syndrome.
One such modiﬁable predictor of frailty may be diabetes8 and its
risk factors. Diabetes risk factors that have recently been shown to be
related to an elevated risk of frailty include adiposity,9 low high-
density lipoprotein (HDL)-cholesterol level,10 high blood pressure,11
and cigarette smoking.12
However, this evidence base is modest; studies are typically small
in scale and cross-sectional in design, and the inﬂuence, if any, of
other diabetes risk factors (history of high blood glucose, physical
activity, consumption of fruit and vegetables, fasting glucose, and
triglycerides) on future frailty is unknown. Additionally, in the clinical
setting, predictive risk algorithms that are in frequent use for the
purposes of predicting diabetes and that comprise these risk factors
offer value in estimating the likelihood of future disease and there-
fore provide clinical guidance in prevention and treatment.
In the present analyses, we examined the longitudinal association
between a comprehensive range of individual diabetes risk factors,
validated diabetes risk algorithms (Framingham Offspring,13 Cam-
bridge,14 and Finnish15), and future frailty. If a strong association
between the diabetes risk scores and frailty is conﬁrmed, these scores
would present a convenient way to identify individuals at an in-
creased risk of frailty later in life and in need of early preventive
measures.
Methods
Study Population
Described in detail elsewhere,16 data were drawn from the
Whitehall II study, an ongoing longitudinal study of 10,308 (67% men)
London-based British civil servants aged 35 to 55 years at study
induction.17 The ﬁrst screening (phase 1) took place from 1985 to
1988, involving a clinical examination and self-administered ques-
tionnaire. Subsequent phases of data collection have alternated
between postal questionnaire alone (phases 2 [1988e1990], 4
[1995e1996], 6 [2001], 8 [2006], and 10 [2011]), and postal ques-
tionnaire accompanied by a clinical examination approximately every
5 to 6 years (phases 3 [1991e1993], 5 [1997e1999], 7 [2002e2004],
and 9 [2007e2009]).
We used diabetes risk factors measured at phase 5, the “baseline”
for the purposes of our analyses. Frailty was assessed approximately
10 years later, at phase 9, when its components were measured for
the ﬁrst time. Diabetes status was assessed at phases 5, 7, and 9.
Prevalent diabetes cases at phase 5 were excluded from the popula-
tion. Ethical approval for the Whitehall II study was obtained from
the University College London Medical School Committee on the
ethics of human research (London, UK).
Diabetes Risk Factors (1997e1999)
Lifestyle indices, anthropometric, and cardiometabolic risk factors
of diabetes were considered. Smoking habit (non, former, and
current), physical activity (<4 h/wk, 4 h/wk), and daily consump-
tion of fruits and vegetables (yes, no) were ascertained by self-
reported questionnaire.
Anthropometric measures included body mass index (BMI)
(calculated by dividing weight, in kilograms, by height, in meters,
squared and categorized using established classiﬁcations18), andwaist circumference taken to be the smallest girth at/or below the
costal margin. The latter was categorized as small (<94 cm in men
and 80 cm in women), intermediate (94 to <102 cm in men and 80
to <88 cm in women), and high (102 cm in men and 88 cm in
women).19 Cardiometabolic measures included use of antihyperten-
sive or corticosteroid medication, measures of systolic and diastolic
blood pressure, fasting and a 2-hour postload glucose, serum total
and HDL-cholesterol, and serum triglycerides. Blood samples were
collected following either an 8-hour overnight fast or at least a 4-hour
fast after a light, fat-free breakfast. Genetic risk was proxied by having
a parent or sibling with a history of diabetes.
Based on measures ascertained at the phase 5 examination, we
calculated the following diabetes risk algorithms: the Framingham
Offspring,13 the Cambridge,14 and the Finnish15 diabetes risk scores.
Supplementary Table 1 summarizes the components of these models.The Fried Frailty Measure (2007e2009)
Comprising 5 individual components, frailty was ascertained
using the Fried frailty scale in 2007 to 2009.20
 Exhaustion: deﬁned using 2 items drawn from the Center
for Epidemiology Studies-Depression (CES-D) scale21: “I felt
that everything I did was an effort in the last week” and “I could
not get going in the last week.” If participants answered
“occasionally or moderate amount of the time (3e4 days)” or
“most or all of the time (5e7 days)” to either of these items,
they were categorized as being exhausted.
 Physical activity: based on a modiﬁed version of the Minnesota
leisure-time physical activity questionnaire22 that includes
20 items on the frequency and duration of participation in
different activities (eg, running, cycling, other sports, house-
work, and gardening activities). Total hours per week were
calculated for each activity and a metabolic equivalent (MET)
valuewas assigned to each based on a compendium of values.23
Energy expenditure (kcal/wk) was then computed for each
participant. Low levels of physical activity were denoted by an
expenditure of less than 383 kcal/wk in men and <270 in
women.
 Walking speed: based on usual walking speed over a distance
of 8 feet (2.4 meters). With established thresholds to denote
risk being based on results for a 15-foot (4.6 meters) walking
test, following downward calibration, participants were cate-
gorized as having slowwalking speed when time to walk 8 feet
for men with height 173 cm was 3.73 seconds or 3.20
seconds with height >173 cm. For women, slow walking time
was3.73 secondswith height159 cm or3.20 secondswith
height >159 cm.
 Grip strength: measured using the Smedley handgrip dyna-
mometer (Scandidact, Odder, Denmark). Thresholds are strat-
iﬁed by gender and BMI. For men, low grip strength was
denoted as 29 kg (BMI24 kg/m2), 30 (BMI 24.1e28.0), and
32 (BMI >28.0). For women, low grip strength was 17 kg
(BMI 23 kg/m2), 17.3 (BMI 23.1e26.0), 18 (BMI 26.1e29.0),
and 21 (BMI >29.0).
 Weight loss: In accordance with that in the Women’s Health
Aging Study-I,24 we used data from 2 assessments (2002e2004
and 2007e2009) to identify weight loss of greater than 10% in
the intervening 5-year period.
A total frailty score was calculated by allocating a value of 1 to
each of the above criteria if present (range: 0 to 5). Participants were
classiﬁed as “frail” if they were positive for at least 3 of 5 of the frailty
Fig. 1. Flow of study members featured in the present analyses through the Whitehall
II data collection phases.
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had none of these components.20
Diabetes
To evaluate the performances of the diabetes risk scores in the
prediction of future frailty, we used diabetes as a reference outcome.
Type 2 diabetes was deﬁned as fasting glucose 7.0 mmol/L or
a 2-hour postload glucose 11.1 mmol/L, and/or as physician-
diagnosed diabetes, and/or use of diabetes medication for those
with diagnosed diabetes.25 To identify only incident (new) cases of
diabetes, people with diabetes at the 1997e1999 screening (n ¼ 450)
were removed from the analyses.
Statistical Analyses
Each diabetes risk factor was described according to frailty status
(frail/prefrail and nonfrail) at the 10-year follow-up and compared
using chi-square tests for the categorical factors and the Wilcoxon
signed-rank test for the continuous factor (age only).
We then used binary logistic regression analyses to examine
the associations between individual risk factors for diabetes and
subsequent frailty. In these analyses, frailty status was dichotomized
(frail/prefrail versus nonfrail) owing to the low number of frail
participants. To test the independence of these associations, we ﬁtted
fully adjusted models using all the risk factors (age, sex, family history
of diabetes, BMI, waist circumference, systolic/diastolic blood pres-
sure, antihypertensive and corticoid treatments, smoking status,
physical activity, daily consumption of fruits and vegetables, fasting
glucose, HDL-cholesterol, and triglycerides). Men and women were
combined in the analyses; however, as sex modiﬁed the relation of
the standardized risk score with frailty for the Cambridge score
(P values for sex interaction ¼ .03), we also reported results stratiﬁed
by sex for this score only.
Logistic regression models were also used to examine the associa-
tion of diabetes risk scores with frailty. These were estimated calcu-
lating the standardized odds ratio (OR) of being frail/prefrail per 1-SD
increase (higher score greater diabetes risk) in the risk scores over the
10-year follow-up. To compare the magnitude of the associations
among the 3 risk scores with future frailty, we calculated a 95% conﬁ-
dence interval (CI) around the difference between the standardized
ORs using a bias-corrected and accelerated (BCa) bootstrap method
with 2000 resamplings.26 To place these effect estimates into context,
we also related diabetes risk scores with incident diabetes.
To examine the robustness of the association between frailty/
prefrailty and the diabetes risk scores, we conducted several sensi-
tivity analyses: in a study sample excluding incident diabetes cases
(sensitivity analysis 1) and in a study sample including prevalent
diabetes cases (sensitivity analysis 2). As the variable assessing
physical activity is included in both the Finnish score and the Fried’s
frailty scale, one may expect to observe a strong relationship between
this score and frailty. To study the use of the diabetes scores in the
prediction of frailty independent of physical activity, we conducted
a further sensitivity analysis (3) using the Fried’s scale without the
physical activity component. In addition, we also imputed data for
missing frailty status and individual diabetes risk factors included in
the 3 studied diabetes risk scores for those participants who re-
sponded to both the questionnaire and attended the screening
examination at baseline (n ¼ 6510) using the method of multiple
imputation by chained equations.27 We imputed missing values
200 times using an SAS-callable software application, IVEware28
(University of Michigan, Ann Arbor, MI; sensitivity analysis 4).
To evaluate the predictive power for each risk score and to esti-
mate its clinical validity, we calculated the area under the receiveroperating characteristic (ROC) curve (AUC).29 To explore the extent to
which the relationship between the risk scores and frailty was driven
by speciﬁc diabetes risk factors included in the scores, analyses on the
risk scoresefrailty associations were adjusted successively for the
individual risk factors one at a time. All analyses were performed
with SAS software, version 9.1 (SAS Institute, Inc, Cary, NC).
This study was approved by the University College London ethics
committee, and participants provided written informed consent.
Results
A total of 2707 participants (755 women) aged 45 to 69 years at
phase 5 constituted the analytic sample; Figure 1 shows the sample
derivation. In comparison with the 5292 study members alive at
phase 9 but excluded (owing to nonparticipation at phases 5 and 9 or
missing data on the diabetes risk scores, plasma glucose, or the frailty
scale), those included in the analytic sample were 0.3 years younger
(P ¼ .005), less likely to be female (27.9% versus 32.7%, P < .0001) and
from the lower socioeconomic group (13.0% versus 22.7%, P < .0001).
Of the 2707 participants, 2.8% were classiﬁed as frail, 37.5% prefrail,
and 59.7% nonfrail. Baseline characteristics of participants as a func-
tion of frailty status at the end of follow-up (on average 10.5 years,
SD ¼ 0.5) are detailed in Table 1. In comparison with nonfrail partici-
pants, frail/prefrail participants were more likely to be older and
female; have higher BMI, waist circumference, and blood pressure; be
a current smoker; and less likely to be physically active and consume
fruits and vegetables on a daily basis. Frail participants were also more
likely to have experienced diabetes during the follow-up relative to
their nonfrail counterparts (11.2% versus 7.4%, P ¼ .0006).
Supplementary Table 2 shows that older age, being a woman,
physical inactivity, and no daily consumption of fruits and vegetables
were independently associated with an increased risk of future
frailty/prefrailty, whereas ex-smokers experienced a decreased risk.
Table 1
Baseline Characteristics and Incident Diabetes in Study Participants (n ¼ 2707)
All Frailty Status at Follow-up P Value*
Not Frail Prefrail/Frail
Numbers 2707 1616 1091
Age, y (SD) 55.0 (5.9) 54.6 (5.6) 55.6 (6.2) .0005
Sex, n (%)
Male 1952 (72.1) 1228 (76.0) 724 (66.4) <.0001
Female 755 (27.9) 388 (24.0) 367 (33.6)
Parental or siblings history of diabetes, n (%)
No 2419 (89.4) 1443 (89.3) 976 (89.5) .89
Yes 288 (10.6) 173 (10.7) 115 (10.5)
Body mass index, kg/m2 .002
<25 1199 (44.3) 730 (45.2) 469 (43.0)
25e30 1145 (42.3) 700 (43.3) 445 (40.8)
30 363 (13.4) 186 (11.5) 177 (16.2)
Waist circumference, cm <.0001
Men: <94/women: <80 1414 (52.2) 879 (54.4) 535 (49.0)
Men: 94e102/women: 80e88 719 (26.6) 442 (27.4) 277 (25.4)
Men: 102/women: 88 574 (21.2) 295 (18.2) 279 (25.6)
Blood pressure 130/85 mm Hg or hypertension therapy, n (%)
No 1629 (60.2) 1005 (62.2) 624 (57.2) .009
Yes 1078 (39.8) 611 (37.8) 467 (42.8)
Corticosteroid treatment, n (%)
No 2608 (96.3) 1562 (96.7) 1046 (95.9) .29
Yes 99 (3.7) 54 (3.3) 45 (4.1)
Smoking status, n (%)
Nonsmoker 1514 (55.9) 891 (55.1) 623 (57.1) .002
Ex-smoker 967 (35.7) 610 (37.8) 357 (32.7)
Current smoker 226 (13.0) 115 (7.1) 111 (10.2)
Low physical activity < 4 h/wk, n (%)
No 968 (35.8) 711 (44.0) 257 (23.6) <.0001
Yes 1739 (64.2) 905 (56.0) 834 (76.4)
Daily consumption of fruits and vegetables, n (%)
No 709 (26.2) 373 (23.1) 336 (30.8) <.0001
Yes 1998 (73.8) 1243 (76.9) 755 (69.2)
Fasting glucose level 100e126 mg/dL, n (%)
No 2292 (84.7) 1370 (84.8) 922 (84.5) .85
Yes 415 (15.3) 246 (15.2) 169 (15.5)
High-density lipoprotein cholesterol, mg/dL .06
Men: <40/women: <50 421 (15.5) 234 (14.5) 187 (17.1)
Men: 40/women: 50 2286 (84.5) 1382 (85.5) 904 (82.9)
Triglycerides level 100 mg/dL .45
No 2109 (77.9) 1267 (78.4) 842 (77.2)
Yes 598 (22.1) 349 (21.6) 249 (22.8)
Incident diabetes at follow-up, n (%)
No 2466 (91.1) 1497 (92.6) 969 (88.8) .0006
Yes 241 (8.9) 119 (7.4) 122 (11.2)
*P for heterogeneity based on chi-square test or Wilcoxon signed-rank test.
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risk scores and frailty/prefrailty and incident diabetes. A 1-SD
increase (disadvantage) in the Framingham and Finnish scores was
associated with a 4% increase in the probability of developing dia-
betes. For the Cambridge score, it represented 18%. Both Cambridge
and Finnish risk scores were associated with future frailty/prefrailty
with OR per 1-SD increment in the score 1.18 (95% CI 1.09e1.27) and
1.27 (95% CI 1.17e1.37), respectively. The Framingham Offspring score
was not associated with future frailty/prefrailty, OR ¼ 1.05 (95% CI
0.98e1.14).
The Finnish risk score had a signiﬁcantly stronger association with
frailty/prefrailty than the other 2 scores, whereas the Cambridge
score also showed a stronger association than the Framingham score
(Table 2).
As anticipated, all risk scores were statistically associated with
incident diabetes in this population, although the Finnish score had
aweaker association than the other 2 scores (Table 2). The associations
between the diabetes scores and frailty/prefrailty changed slightly
after exclusion of incident diabetes cases over the follow-up, inclusion
of prevalent diabetes, modiﬁcation of the Fried’s scale (original scalewithout physical activity component), and multiple imputations, but
the ranking of their associations with frailty/prefrailty wasmaintained
(Supplementary Table 3).
Supplementary Table 4 presents results of analyses in which the
3 diabetes scores as a whole were adjusted for each of their risk
factors. For the Cambridge and Finnish scores, the association with
frailty/prefrailty remained statistically signiﬁcant after successive
adjustments for risk factors, suggesting that this association was not
driven by any one speciﬁc risk factor.
Table 3 shows the AUC for each diabetes score in the prediction of
frailty/prefrailty. The Finnish score had the highest AUC compared
with the other scores (0.58 versus 0.53 and 0.54 for the Framingham
and Cambridge scores, respectively). In the prediction of diabetes, the
Framingham score had the highest AUC (0.76 versus 0.68 and 0.70 for
the Finnish and Cambridge scores, respectively).
Discussion
In this middle-aged cohort, we examined diabetes risk factors, and
various diabetes risk engines, as predictors of future frailty. Our main
Table 2
Comparison of Performances of Diabetes Risk Scores* in the Prediction of Future Frailty and Diabetes
Difference (D) in ORy (95% CI)z for Frailty
Framingham Risk Score OR ¼ 1.05 (0.98e1.14) Cambridge Risk Score OR ¼ 1.18 (1.09e1.27)
Framingham risk score OR ¼ 1.05 (0.98e1.14) d d
Cambridge risk score OR ¼ 1.18 (1.09e1.27) D ¼ 0.12 (0.02e0.22) d
Finnish risk score OR ¼ 1.27 (1.17e1.37) D ¼ 0.22 (0.11e0.33) D ¼ 0.09 (0.02e0.17)
Difference (D) in OR (95% CI)* for Diabetes
Framingham Risk Score OR ¼ 1.72 (1.56e1.90) Cambridge Risk Score OR ¼ 1.69 (1.52e1.88)
Framingham risk score OR ¼ 1.72 (1.56e1.90) d d
Cambridge risk score OR ¼ 1.69 (1.52e1.88) D ¼ 0.03 (0.28e0.21) d
Finnish risk score OR ¼ 1.52 (1.38e1.68) D ¼ 0.20 (0.46e0.01) D ¼ 0.17 (0.32 to 0.05)
CI, conﬁdence interval; OR, odds ratio; d, not applicable.
*A 1-SD increase (disadvantage) in the Framingham and Finnish scores was associated with a 4% increase in the probability of developing diabetes. For the Cambridge score,
it represented 18%.
yORs are per 1-SD increment in score.
zBias-corrected and accelerated bootstrap (BCa) 95% CI.
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Moreover, we showed that risk prediction using established diabetes
models was modest and smaller than that apparent for the diabetes.
Risk factors associated with frailty were increased age, being female,
and 2 markers of unhealthy behaviors (physical activity less than
4 hours per week and no daily consumption of fruits and vegetables)
and 1 marker of healthy behavior (stopping smoking).
Age is an obvious predictor of frailty/prefrailty.30 Greater risk
of frailty/prefrailty among women is also well known.30 The strong
relationship between physical inactivity and subsequent frailty/
prefrailty is to be expected given that it is also 1 of the 5 components
of Fried’s frailty measurement.20 However, frailty/prefrailty deﬁned
with the Fried’s scale without the physical activity component
showed a similar level of association. This association is also plausible
because inactivity is related to an accelerated loss of lean mass due to
a decrease in muscle ﬁbers leading to a low physical capability.31 One
plausible mechanism linking fruit and vegetable consumption and
frailty may be the antioxidant effect of nutrients in fruits and vege-
tables, such as carotenoids, vitamins (C, E), and phenolics. These
antioxidants have been shown to inhibit lipid peroxidation in vitro,
particularly that of low-density lipoproteins (LDL)32 responsible for
the development of atherosclerosis,33 the primary cause of cardio-
vascular diseases, which have been shown to be related to frailty in
several cross-sectional studies.34 Although several prospective
studies demonstrated that fruit and vegetable consumption is
protective against noncommunicable diseases, particularly cardio-
vascular diseases,35 the beneﬁcial effect may not be due to isolated
individual antioxidant compounds included in fruits and vegetables,
as important meta-analyses of randomized controlled trials failed to
show a beneﬁcial effect of vitamins E, C, or b-carotene,36 rather joint
effects of known or unknown antioxidants. In addition, we cannot
rule out other mechanisms besides the antioxidant effect that explain
such associations. Several researchers support the notion that fruit
and vegetable intake is a marker of healthy lifestyle behavior rather
than an etiological factor of noncommunicable diseases, as it is highly
correlated with other disease risk factors.37 Although a few studiesTable 3
Comparisons of the AUCs and Their 95% CIs in the Prediction of Frailty and Diabetes
Frail and Prefrail
AUC (95% CI) D (95% CI)*
Framingham risk score 0.531 (0.509e0.553) 0.044 (0.02
Cambridge risk score 0.535 (0.513e0.557) 0.040 (0.02
Finnish risk score 0.575 (0.553e0.597) Ref
AUC, area under the receiver operating curve; CI, conﬁdence interval.
*Difference in the AUCs.found that smokers are at high risk of frailty/prefrailty,38,39 to our
knowledge, no other studies have reported a beneﬁcial effect of
stopping smoking on frailty/prefrailty. This positive healthy behavior
was also observed in this study when looking at cognitive function:
ex-smokers had lower risk of poor cognition.40 Greater beneﬁcial
health effects among those who give up smoking compared with
nonsmokers may be due to a greater improvement in other health
behaviors.
The higher magnitude of association and prediction between the
Finnish score and frailty may be due to its composition: this model
included the risk factors that were more strongly associated with
frailty as seen previously in this article. This association was not
driven by any one speciﬁc risk factor included in this score. In
particular, physical inactivity, which is also included in the oper-
ationalization of the Fried frailty measure, was not solely responsible
for the stronger association. Smaller associations of the Cambridge
and Framingham risk scores with frailty may be explained by the
effect of sex, as the direction of the association was unexpected in the
prediction of frailty. In addition, 3 strong predictors of frailty were not
included. Indeed, old women are more likely to become frail than old
men,30 whereas in the prediction of diabetes, sex has a nonsigniﬁcant
effect in the Framingham score (b for men ¼ 0.01) and women are
less at risk in the Cambridge score (b for women ¼ 0.88).
Our study has some limitations. First, we identiﬁed frailty cases
using a measure operationalized by Fried and colleagues,20 but
a recent review identiﬁed more than 20 alternative measures of
frailty.41 Although there are no gold standard measures, the measure
by Fried and colleagues20 is the most widely used. Second, contrary to
cardiovascular diseases whose gold standard risk score is the Fra-
mingham risk score and that is routinely used in clinical and public
health practice, there is no such gold standard for diabetes. Although
there are numerous diabetes risk scores, they are less known and
used.42 However, in the literature, the 3 risk scores that we used were
widely validated and well known compared with other diabetes risk
scores. Third, our study sample consisted of middle-aged civil
servants, limiting the generalizability of our ﬁndings. However, theseDiabetes
AUC (95% CI) D (95% CI)*
2e0.066) 0.760 (0.727e0.792) Ref
3e0.057) 0.699 (0.666e0.732) 0.061 (0.025e0.097)
0.684 (0.649e0.718) 0.076 (0.040e0.112)
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which resides in the use of prospectively collected data that allowed
us to test an original hypothesis.Conclusion
In conclusion, diabetes risk scores, in particular the Finnish score,
were associated with future frailty. Our ﬁndings may help in the
construction of an original prediction model to identify middle-aged
persons at risk of frailty.Acknowledgments
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